Cargando…

ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function

Both LRF (Zbtb7a) and ThPOK (Zbtb7b) belong to the POK (BTB/POZ and Kruppel) family of transcription repressors that participate in development, differentiation, and oncogenesis. Although LRF mediates osteoclast differentiation by regulating NFATc1 expression, the principal established function of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Wei, Izawa, Takashi, Rohatgi, Nidhi, Zou, Steven Y, Li, Yongjia, Teitelbaum, Steven L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009119/
https://www.ncbi.nlm.nih.gov/pubmed/35434449
http://dx.doi.org/10.1002/jbm4.10613
_version_ 1784687207699709952
author Zou, Wei
Izawa, Takashi
Rohatgi, Nidhi
Zou, Steven Y
Li, Yongjia
Teitelbaum, Steven L
author_facet Zou, Wei
Izawa, Takashi
Rohatgi, Nidhi
Zou, Steven Y
Li, Yongjia
Teitelbaum, Steven L
author_sort Zou, Wei
collection PubMed
description Both LRF (Zbtb7a) and ThPOK (Zbtb7b) belong to the POK (BTB/POZ and Kruppel) family of transcription repressors that participate in development, differentiation, and oncogenesis. Although LRF mediates osteoclast differentiation by regulating NFATc1 expression, the principal established function of ThPOK is transcriptional control of T‐cell lineage commitment. Whether ThPOK affects osteoclast formation or function is not known. We find that marrow macrophage ThPOK expression diminishes with exposure to receptor activator of NF‐kB ligand (RANKL), but ThPOK deficiency does not affect osteoclast differentiation. On the other hand, enhanced ThPOK, in macrophages, substantially impairs osteoclastogenesis. Excess ThPOK binds the NFATc1 promoter and suppresses its transcription, suggesting a mechanism for its osteoclast inhibitory effect. Despite suppression of osteoclastogenesis by excess ThPOK being associated with diminished NFATc1, osteoclast formation is not rescued by NFATc1 overexpression. Thus, ThPOK appears to inhibit NFATc1 transcription and its osteoclastogenic capacity, while its depletion has no effect on the bone‐resorptive cell. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-9009119
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-90091192022-04-15 ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function Zou, Wei Izawa, Takashi Rohatgi, Nidhi Zou, Steven Y Li, Yongjia Teitelbaum, Steven L JBMR Plus Research Articles Both LRF (Zbtb7a) and ThPOK (Zbtb7b) belong to the POK (BTB/POZ and Kruppel) family of transcription repressors that participate in development, differentiation, and oncogenesis. Although LRF mediates osteoclast differentiation by regulating NFATc1 expression, the principal established function of ThPOK is transcriptional control of T‐cell lineage commitment. Whether ThPOK affects osteoclast formation or function is not known. We find that marrow macrophage ThPOK expression diminishes with exposure to receptor activator of NF‐kB ligand (RANKL), but ThPOK deficiency does not affect osteoclast differentiation. On the other hand, enhanced ThPOK, in macrophages, substantially impairs osteoclastogenesis. Excess ThPOK binds the NFATc1 promoter and suppresses its transcription, suggesting a mechanism for its osteoclast inhibitory effect. Despite suppression of osteoclastogenesis by excess ThPOK being associated with diminished NFATc1, osteoclast formation is not rescued by NFATc1 overexpression. Thus, ThPOK appears to inhibit NFATc1 transcription and its osteoclastogenic capacity, while its depletion has no effect on the bone‐resorptive cell. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2022-03-14 /pmc/articles/PMC9009119/ /pubmed/35434449 http://dx.doi.org/10.1002/jbm4.10613 Text en © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zou, Wei
Izawa, Takashi
Rohatgi, Nidhi
Zou, Steven Y
Li, Yongjia
Teitelbaum, Steven L
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
title ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
title_full ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
title_fullStr ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
title_full_unstemmed ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
title_short ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
title_sort thpok inhibits osteoclast formation via nfatc1 transcription and function
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009119/
https://www.ncbi.nlm.nih.gov/pubmed/35434449
http://dx.doi.org/10.1002/jbm4.10613
work_keys_str_mv AT zouwei thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction
AT izawatakashi thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction
AT rohatginidhi thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction
AT zousteveny thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction
AT liyongjia thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction
AT teitelbaumstevenl thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction